BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12473953)

  • 1. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Favorable outcome of gemcitabine-induced acute respiratory distress syndrome].
    Bonnichon A; Vedrine L; Aletti M; Le Moulec S; Borne M; Margery J; Bauduceau O; Fayolle M; Ceccaldi B
    Rev Pneumol Clin; 2007 Dec; 63(6):379-83. PubMed ID: 18166944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
    Pavlakis N; Bell DR; Millward MJ; Levi JA
    Cancer; 1997 Jul; 80(2):286-91. PubMed ID: 9217042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe pulmonary toxicity in a patient treated with gemcitabine.
    Rosado MF; Kett DH; Schein RM; Baraona FJ; Sridhar KS
    Am J Clin Oncol; 2002 Feb; 25(1):31-3. PubMed ID: 11823691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autopsy case of acute pulmonary toxicity associated with gemcitabine.
    Maniwa K; Tanaka E; Inoue T; Kato T; Sakuramoto M; Minakuchi M; Maeda Y; Noma S; Kobashi Y; Taguchi Y
    Intern Med; 2003 Oct; 42(10):1022-5. PubMed ID: 14606719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of drug-induced interstitial pneumonitis after adjuvant chemotherapy with gemcitabine for bile duct cancer].
    Mori R; Misuta K; Sasaki M; Murakami T; Tokuhisa M; Hasegawa S; Eguchi K; Nakano A
    Gan To Kagaku Ryoho; 2010 May; 37(5):923-6. PubMed ID: 20495330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side effects of chemotherapy. Case 3. Acute interstitial pneumonitis related to gemcitabine.
    Attar EC; Ervin T; Janicek M; Deykin A; Godleski J
    J Clin Oncol; 2000 Feb; 18(3):697-8. PubMed ID: 10653887
    [No Abstract]   [Full Text] [Related]  

  • 8. Gemcitabine-induced pulmonary toxicity: case report and review of the literature.
    Gupta N; Ahmed I; Steinberg H; Patel D; Nissel-Horowitz S; Mehrotra B
    Am J Clin Oncol; 2002 Feb; 25(1):96-100. PubMed ID: 11823707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable outcome of gemcitabine-induced respiratory distress syndrome.
    Girard T; Mouthon L; Boaziz C; Andre MH; Guillevin L
    Ann Med Interne (Paris); 2000 Jun; 151(4):306-8. PubMed ID: 10922960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis].
    Mommens V; Bosquée L; D'Orio V
    Rev Med Liege; 2003 Mar; 58(3):123-6. PubMed ID: 12723505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interstitial pneumonitis due to gemcitabine].
    San José Ruiz B; Molas Ferrer G; Castro Rebollo P; Soy Muner D
    Farm Hosp; 2012; 36(5):452-3. PubMed ID: 22871364
    [No Abstract]   [Full Text] [Related]  

  • 12. Gemcitabine pulmonary toxicity: CT features.
    Boiselle PM; Morrin MM; Huberman MS
    J Comput Assist Tomogr; 2000; 24(6):977-80. PubMed ID: 11105721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gemcitabine in the treatment of non-small cell lung cancer for elderly patients].
    Furuse K
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):890-7. PubMed ID: 10396315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma.
    Galvão FH; Pestana JO; Capelozzi VL
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):607-10. PubMed ID: 19904536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine-induced systemic capillary leak syndrome.
    De Pas T; Curigliano G; Franceschelli L; Catania C; Spaggiari L; de Braud F
    Ann Oncol; 2001 Nov; 12(11):1651-2. PubMed ID: 11822767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report.
    Fenocchio E; Depetris I; Campanella D; Garetto L; Schianca FC; Galizia D; Grignani G; Aglietta M; Leone F
    BMC Cancer; 2016 Oct; 16(1):793. PubMed ID: 27733144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Veno-occlusive disease of the liver induced by gemcitabine.
    Dobbie M; Hofer S; Oberholzer M; Herrmann R
    Ann Oncol; 1998 Jun; 9(6):681. PubMed ID: 9681086
    [No Abstract]   [Full Text] [Related]  

  • 18. Gemcitabine for lung cancer.
    Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
    [No Abstract]   [Full Text] [Related]  

  • 19. Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer.
    Umemura S; Yamane H; Suwaki T; Katoh T; Yano T; Shiote Y; Takigawa N; Kiura K; Kamei H
    J Cancer Res Clin Oncol; 2011 Oct; 137(10):1469-75. PubMed ID: 21818557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic-uremic syndrome caused by gemcitabine.
    Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
    Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.